Important Data on COVID-19 Profile in Africa

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

574 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-01

Study Completion Date

2022-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to Understand the natural history of Coronavirus 2019 (COVID-19) infection to better define the period of infectiousness and transmissibility and to establish biobanks of COVID-19 blood and mucosal samples.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19)

NCT04473365

SARS-CoV-2 COVID-19

COMPLETED

COVID-19 Quick Start - Test and Treat in Africa

NCT06360783

COVID-19

ACTIVE_NOT_RECRUITING

Observational Study of the Clinico-biological Evolution and Standard of Care Offered to Patients With Ebola Virus Disease

NCT04815174

Ebola Virus Disease

COMPLETED

Clinical Outcomes of paTients pREsenting to HArare COVID-19 CenTer of Excellence With SARS-CoV-2 Infection

NCT05529771

COVID-19

COMPLETED

Collection of Tissue Specimens in Mali, West Africa, for HIV and Tuberculosis Research

NCT00341042

Tuberculosis HIV

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study ,the participants will be enrolled sequentially in the COVID-19 care referral centers. The infected hospitalized patient will be identified by the physicians in hospital. After the patient has given his/her informed consent the permission will be sought from him to approach his household contacts. The household contacts will be screened, and included in the study.

Patients hospitalized and positive for COVID-19 by PCR and their household contacts of all ages and gender (40% minimum of female), will be enrolled upon receipt of written informed consent.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronavirus Infection Africa

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Index cases

Patients infected by SARS-Cov2 Polymerase Chain Reaction (PCR) and hospitalized in a referral center for COVID-19 .

No interventions assigned to this group

Households cases

Household contacts of SARS-Cov2 hospitalized COVID-19 patients.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Molecular (PCR) confirmed COVID-19 patients hospitalized in referral centers,
* Household contacts of hospitalized COVID-19 patient,
* Provided signed informed consent.